Abstract
I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 969-971 |
| Number of pages | 3 |
| Journal | Clinical pharmacology and therapeutics |
| Volume | 91 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2012 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)